
Epoxy Accelerators with High-Latency & Rapid-Curing for Composite Applications
Key Benefits |
||||||
![]() |
Up to 2 times faster cure | ![]() |
Up to 30 times longer shelf-life stability | |||
![]() |
Lower Curing Temperature reducing energy load | ![]() |
Long process stability for operational flexibility | |||
![]() |
Cost savings through reduction of quality costs | ![]() |
Elimination of cold chain storage |
Key Markets
![]() |
![]() |
![]() |
Automotive
|
Aerospace
|
Sports and Leisure
|
Property | Catalyx™ H210/H310 | Traditional Accellerators Urone, Imidazole |
|
Shelf Life (Ambient) | 1 to 4 months | 1 to 3 months, refrigerated | |
Cold Chain required | No | Yes | |
Cure Speed | 2x faster | Standard | |
Process Stability (70-80°C) | Stable | Rapid viscosity increase |
Disclaimer: All statements, information and data presented herein are intended to describe possible characteristics and applications of Calyxia products™, based on internal development efforts and preliminary evaluations. They are provided without guarantee, warranty, or representation of any kind, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, or freedom from intellectual property infringement.
Statements or suggestions concerning potential uses of our products do not constitute a recommendation to infringe any patent, nor assurance of regulatory compliance in any specific jurisdiction. Users must conduct their own tests and validations to determine product suitability for their intended application, environment, and compliance context.
The user should not assume that all safety or regulatory considerations are addressed herein, nor that additional measures will not be required. Calyshield™, Catalyx™, ActivOptix™, CalyCare™ and NaturaCaps™ are trademarks of Calyxia. These trademark are registered in certain jurisdictions; trademark registration status may vary by country.